Jefferson Center for Mental Health Clear Creek Office
-
Services:
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- Testing for Hepatitis B (HBV)
- HIV testing
- Intensive outpatient treatment
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Discharge Planning
- Aftercare/continuing care
- Outcome follow-up after discharge
- Naloxone and overdose education
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Trauma-related counseling
- Cognitive behavioral therapy
- Substance use disorder counseling
- Motivational interviewing
- Telemedicine/telehealth therapy
- Brief intervention
- Relapse prevention
- Non-nicotine smoking/tobacco cessation
- Buprenorphine (extended-release, injectable)
- Naltrexone (oral)
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Acamprosate (Campral®)
- Clonidine
- Nicotine replacement
- Medication for mental disorders
- Disulfiram
- Female
- Male
- Sliding fee scale (fee is based on income and other factors)
- Private non-profit organization
- Case management service
- Mental health services
- Social skills development
- Suicide prevention services
- This facility administers/prescribes medication for alcohol use disorder
- Professional interventionist/educational consultant
- Screening for tobacco use
- Screening for substance use
- Interim services for clients
- Screening for mental disorders
- Comprehensive substance use assessment
- Comprehensive mental health assessment
- Outreach to persons in the community
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Individual counseling
- Family counseling
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Group counseling
- Smoking/vaping/tobacco cessation counseling
- Mentoring/peer support
- Employment counseling or training
- Assistance with obtaining social services
- Housing services
- Recovery coach
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- State mental health department
- State Substance use treatment agency
- Prescribes naltrexone
- Prescribes buprenorphine
- Buprenorphine maintenance
- Relapse prevention with naltrexone
- Private health insurance
- Medicare
- Cash or self-payment
- Medicaid
- Federal military insurance (e.g., TRICARE)
- SAMHSA funding/block grants
- Federal, or any government funding for substance use treatment programs
- Vaping not permitted
- Other contracted prescribing entity
- In-network prescribing entity
- No formal relationship with prescribing entity
- Smoking not permitted
- Clients with co-occurring mental and substance use disorders
- Veterans
- Active duty military
- Young adults
- Adult women
- Adult men
- Adolescents
- Members of military families
- Clients who have experienced sexual abuse
- Clients who have experienced trauma
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Clients with co-occurring pain and substance use disorders
- Clients who have experienced intimate partner violence, domestic violence
- Criminal justice (other than DUI/DWI)/Forensic clients
- Seniors or older adults
Testing
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Transitional Services
Opioid Medications used in Treatment
Treatment Approaches
Pharmacotherapies
Gender Accepted
Payment Assistance Available
Facility Operation (e.g., Private, Public)
Ancillary Services
Type of Alcohol Use Disorder Treatment
Assessment/Pre-treatment
Education and Counseling Services
Recovery Support Services
Type of Care
License/Certification/Accreditation
Type of Opioid Treatment
Payment/Insurance/Funding Accepted
Facility Vaping Policy
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Smoking Policy
Special Programs/Groups Offered